top of page


Getting a better deal for people with rare and less common cancers: the next ten years
We're excited to announce the publication of our new briefing document 'Getting a better deal for people with rare and less common...
The UK team has crossed the finish line of the C2C4C challenge!
Yesterday afternoon, the Bristol-Myers Squibb (BMS) UK team cycled into Uxbridge, marking the end of this year’s Country 2 Country 4...
One week into the C2C4C challenge and the UK team are raring to go!
We are now over one week into this years’ Bristol-Myers Squibb (BMS) Country 2 Country 4 Cancer (C2C4C) cycling challenge, meaning we are...
This year’s #C2C4Cancer bike ride has begun!
This Monday, the Bristol-Myers Squibb (BMS) Country 2 Country 4 Cancer (C2C4C) bike ride set off for another year. It's a pan-European...


New Cancer52 films on the importance of data for rare and less common cancers
Because we believe so strongly in the importance of access to data for rare and less common cancers Cancer52 has worked with Public...


Cancer52 at PHE Cancer Services, Data and Outcomes Conference 2018
Cancer52 will have an active presence at the forthcoming PHE Cancer Services, Data and Outcomes Conference taking place in Manchester, 20...
Safeguarding interests of cancer patients during second phase of Brexit negotiations
Cancer52 has today (20 March 2018) come together with 18 other cancer charities, calling on Government to prioritise the interests of...
Cancer52 at Britain Against Cancer 2017
Cancer52 is sharing Orchid’s stand, and handing out awareness raising postcards and briefing documents and running two breakout sessions...


Cancer52 hosts parliamentary reception
Cancer52 organised a parliamentary reception which was attended by some 32 charity members, 22 patients and carers, and 19 MPs. The...


Country 2 Country 4 Cancer
A team of 10 novice bikers from Bristol-Myers Squibb participated in Country 2 Country 4 Cancer, an epic annual cycling event which set...
bottom of page
